BREAKING NEWS: New drug approved by the FDA for Duchenne muscular dystrophy. Learn more about this new treatment option.

Medical Educational Resource

We're accelerating the delivery of treatments and cures.

Updates in Myotonic Dystrophy

Activity Snapshot

Activity Type: 
Live, Virtual Webinar
Release Date: 
Thursday, January 12, 2023

Faculty

Sheetal Shroff, MD
Assistant professor of clinical neurology, Stanley H. Appel Department of Neurology
Houston Methodist Neurological Institute
Activity Overview: 

This webinar, featuring Dr. Sheetal Shroff of Houston Methodist Neurological Institute, explores Myotonic Dystrophy and its current treatment landscape. Topics discussed will included diagnosis, treatment options and new and ongoing research updates.

Download Clinical Flashcard